Eric B. Fox, D.O. | Hematology/Oncology


Internal Medicine
Board Certified in 2019

Board Certified in 2022

Board Certified in 2022


Bryn Mawr Medical Arts Pavilion
825 Old Lancaster Road
Suite 440
Bryn Mawr, PA 19010

Phone: (610) 525-4511
Fax: (610) 525-8561

Practice Philosophy

I aim to provide the most cutting edge, evidence-based care to my patients. I combine this with a focus on compassion by individualizing care for every patient and their family’s unique circumstances.


The George Washington University- 2010

Touro College of Osteopathic Medicine- 2016

Main Line Health- Internal Medicine Residency- 2019

Main Line Health- Hematology Oncology Fellowship- 2022


Alliance Cancer Specialists- 2022-2023




PIER Oncology Physician Investigator Advisory Committee

Bloodless Medicine Committee

Blood Transfusion Committee

Research Review Committee- Main Line Health

Sickle Cell Patients Order Review Committee


Dillon, M, Fox E, Zeger E. Peritoneal Carcinomatosis Secondary to Metastatic Testicular Seminoma. Poster presented at: Society of Hospital Medicine – South Central PA Chapter Academic Day and Poster Competition; October 2021; Bethlehem, PA.     

Fox E, Kennedy AS, Katz J. Gallbladder Cancer. Medscape Drugs & Diseases. Updated Sept 30, 2021

Fox E, Patel N, Patel A. A Farmer With Diffuse Pruritus and a Suntan That Won’t Fade. Medscape. 2021 June.

Fox E, Oliver T, Vitorsky O, Rowe M, Cohen DA. Bilateral Adrenal Hemorrhage causing Adrenal Insufficiency in the Setting of Antiphospholipid Syndrome. ACP Hospitalist. 2019 May. Online only

Fox E, Oliver T, Rowe M, Gilman P, Thomas S, Muller AJ, Prendergast GC. Indoximod: an immunometabolic adjuvant that empowers T cell activity in cancer. Frontiers in Oncology. 2018 Sep 11;8:370. PMID 30254983

Fox E, Dabrow, M, Ochsner G. A Case of Nivolumab Induced Myositis. Oncologist. 2016 Dec;21(12)e3. Epub 2016 PMID: 27864576

Golovine K, Makhov P, Uzzo RG, Kutikov A, Kaplan DJ, Fox E, Kolenko VM. Cadmium down-regulates expression of XIAP at the post-transcriptional level in prostate cancer cells through an NF-kappaB-independent, proteasome-mediated mechanism. Molecular Cancer. 2010 Jul 9;9:183. PMID 20618956

Crispen PL, Viterbo R, Fox EB, Greenberg RE, Chen DY, Uzzo RG.

Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer. 2008 Mar 1;112(5):1051-7. PMID: 18286513

Rothman J, Crispen PL, Wong YN, Al-Saleem T, Fox E, Uzzo RG. Pathologic Concordance of sporadic synchronous bilateral renal masses. Urology. 2008 Jul;72(1):138-42. Epub 2008 Mar 12. PMID: 18336882

Are you ready for our Jumpstart© with OPTIFAST® Program?

Let’s get started! Answer a few basic questions to see if Jumpstart© with OPTIFAST® Program is right for you.

We commit our TIME to you. Can you...commit to once weekly attendance in the evenings?
We commit ACCOUNTABILITY for your needs.Can you...commit to daily written tracking of nutrition and activity?
We commit ENCOURAGEMENT for your goal.Can you...commit to beginning planned physical activity?
This field is for validation purposes and should be left unchanged.